6 results  1 of 1 

1 Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
Jae Hee Cheon
J Rheum Dis.2021;28(1):4-16.   Published online 2021 January 1     DOI: http://dx.doi.org/10.4078/jrd.2021.28.1.4
      
2 Clinical aspects and treatments for pediatric inflammatory bowel diseases
Jin Soo Moon
Intest Res.2019;17(1):17-23.   Published online 2019 January 9     DOI: http://dx.doi.org/10.5217/ir.2018.00139
      
3 Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
Tadakazu Hisamatsu, Mari Hayashida
Intest Res.2017;15(3):318-327.   Published online 2017 June 12     DOI: http://dx.doi.org/10.5217/ir.2017.15.3.318
      
4 Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients
Jae Myung Cha, Dong Il Park, Sang Hyoung Park, Jeong Eun Shin, Wan Soo Kim, Suk-Kyun Yang
J Korean Med Sci.2017;32(1):85-94.   Published online 2016 November 24     DOI: http://dx.doi.org/10.3346/jkms.2017.32.1.85
      
5 Tuberculous Peritonitis in a Patient with Rheumatoid Arthritis Treated with Infliximab
In Tae Kim, Hyung Bok Park, Sang Hun Lee, Yu Kyung Hyun, Yun Ji Kim, Yong Won Lee, Jung-Soo Song, Sang Tae Choi
J Rheum Dis.2011;18(4):320-323.   Published online 2011 December 31     DOI: http://dx.doi.org/10.4078/jrd.2011.18.4.320
   
6 Anti-TNF-α Therapy in Rheumatic Diseases with Chronic Hepatitis B Virus Infection
Hye-Ryeon Yun, Tae-Jong Kim, Tae-Hwan Kim, Ho Soon Choi, Sang-Cheol Bae
J Korean Rheum Assoc.2007;14(3):242-250.   Published online 2007 September 23     DOI: http://dx.doi.org/10.4078/jkra.2007.14.3.242
   

 1 of 1